REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,752 | -7.3% | 250 | 0.0% | 0.02% | 0.0% |
Q2 2023 | $42,890 | +1.9% | 250 | 0.0% | 0.02% | -4.8% |
Q1 2023 | $42,090 | -0.6% | 250 | 0.0% | 0.02% | -4.5% |
Q4 2022 | $42,327 | -9.9% | 250 | 0.0% | 0.02% | -15.4% |
Q3 2022 | $47,000 | +14.6% | 250 | 0.0% | 0.03% | +18.2% |
Q2 2022 | $41,000 | -12.8% | 250 | 0.0% | 0.02% | 0.0% |
Q1 2022 | $47,000 | -28.8% | 250 | 0.0% | 0.02% | -29.0% |
Q4 2021 | $66,000 | -9.6% | 250 | 0.0% | 0.03% | -11.4% |
Q3 2021 | $73,000 | +46.0% | 250 | 0.0% | 0.04% | +40.0% |
Q2 2021 | $50,000 | +2.0% | 250 | 0.0% | 0.02% | -3.8% |
Q1 2021 | $49,000 | -2.0% | 250 | 0.0% | 0.03% | -13.3% |
Q4 2020 | $50,000 | +233.3% | 250 | +150.0% | 0.03% | +200.0% |
Q3 2020 | $15,000 | 0.0% | 100 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $15,000 | +50.0% | 100 | 0.0% | 0.01% | +25.0% |
Q1 2020 | $10,000 | 0.0% | 100 | 0.0% | 0.01% | +14.3% |
Q4 2019 | $10,000 | +25.0% | 100 | 0.0% | 0.01% | +16.7% |
Q3 2019 | $8,000 | – | 100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |